Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Oliceridine and its potential to revolutionize GI endoscopy sedation
Basavana Goudra,
Preet Singh
Division of Obstetrical Anesthesia
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oliceridine and its potential to revolutionize GI endoscopy sedation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Propofol
100%
Sedation
100%
Gastrointestinal Endoscopy
100%
Oliceridine
100%
Anesthesia Provider
40%
Remimazolam
40%
Failure Rate
20%
Morphine
20%
Receptor Agonist
20%
Midazolam
20%
Gastrointestinal
20%
G Protein
20%
Respiratory Depression
20%
Fentanyl
20%
Opioids
20%
Endoscopic Surgery
20%
Prodrug
20%
Airway Management
20%
Analgesic Properties
20%
Screening Colonoscopy
20%
Computer-assisted Personalized Sedation
20%
Sedasys
20%
Fospropofol
20%
Commercial Success
20%
Property Rate
20%
Biased Receptor
20%
Adverse Effect Profile
20%
Nursing and Health Professions
Sedation
100%
Gastrointestinal Endoscopy
100%
Oliceridine
100%
Propofol
83%
Respiration Depression
66%
Remimazolam
33%
Adverse Event
16%
Duragesic
16%
Morphine
16%
Colonoscopy
16%
Food and Drug Administration
16%
Prodrug
16%
Receptor
16%
Analgesic Agent
16%
Infusion System
16%
Midazolam
16%
Airway Management
16%
Guanine Nucleotide Binding Protein
16%
Fospropofol
16%
Medicine and Dentistry
Propofol
100%
Gastrointestinal Endoscopy
100%
Oliceridine
100%
Respiration Depression
80%
Remimazolam
40%
Health Care Cost
20%
Adverse Event
20%
Receptor
20%
Morphine
20%
Midazolam
20%
Guanine Nucleotide Binding Protein
20%
Fentanyl
20%
Prodrug
20%
Colonoscopy
20%
Airway Management
20%
Fospropofol
20%
Pharmacology, Toxicology and Pharmaceutical Science
Propofol
100%
Oliceridine
100%
Respiration Depression
80%
Remimazolam
40%
Adverse Event
20%
Receptor Agonist
20%
Analgesic Agent
20%
Guanine Nucleotide Binding Protein
20%
Prodrug
20%
Morphine
20%
Duragesic
20%
Midazolam
20%
Fospropofol
20%